switching between glp 1 agonists chart agonist conversion GLP‐1 receptor in clinical practice: Expert Switching to Tirzepatide 5 mg
Description
Highlights of prescribing information: Saxenda (liraglutide) injection, for subcutaneous use
Need Expert Guidance on This Topic
It was based on an average annual drug cost of $5,600 in 2026, decreasing to $4,300 in 2034
These older medications produce less dramatic weight loss compared to semaglutide and tirzepatide, which supports the theory that the rate and magnitude of weight loss, rather than the GLP-1 receptor activation itself, drives most of the hair shedding
for example, liraglutide and exendin-4 normalized glucose metabolism and prevented weight loss in a transgenic HD model (58)
